FDA approves Emergent BioSolutions' anthrax treatment

March 25, 2015 11:55 AM

8 0

FDA approves Emergent BioSolutions' anthrax treatment

(Reuters) - Emergent BioSolutions Inc said the U.S. Food and Drug Administration approved its treatment for inhaled anthrax, triggering a $7 million milestone payment from the U.S. Department of Health and Human Services (HHS).

Emergent Bio developed the treatment, Anthrasil, as part of a $160 million contract it signed in 2005 with the Biomedical Advanced Research and Development Authority (BARDA), a part of the HHS.

Also read: FDA approves Newron's drug as add-on therapy for Parkinson's

Read more

To category page

Loading...